awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37427337-05B0A8EE-A4AB-4EA2-9989-97F78772651D
Q37427337-05B0A8EE-A4AB-4EA2-9989-97F78772651D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37427337-05B0A8EE-A4AB-4EA2-9989-97F78772651D
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines.
P2860
Q37427337-05B0A8EE-A4AB-4EA2-9989-97F78772651D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37427337-05B0A8EE-A4AB-4EA2-9989-97F78772651D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2cdb86d6c91521fe7baec7acc5b4d66a534fddf3
P2860
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors.